NCT07420283
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07420283
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07420283
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE2
- Indication
- Opioid Use Disorder
- Status
- RECRUITING
- Start date
- 2026-02-13
- Primary completion
- 2028-03
- Registered countries
- Canada, Puerto Rico, United Kingdom, United States
- Sites
- 68
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-11-07
Notes on the record
Supersedes the row verified 2026-10-19 (kept), per DATA LAYER rule 4. Read live from the ClinicalTrials.gov v2 API 2026-11-07 (https://clinicaltrials.gov/api/v2/studies/NCT07420283); record last update posted 2026-11-04. site_count 61 to 68 location entries; status, dates and the four countries unchanged (no EU member state). Flagged by the collector (inbox/2026-11-05.json); collector proposal replaced by this live read.
Company
Through brenipatide (LY3537031): Lilly
Cited in
No published issue cites this registry number.